$378.6 M

CRVS Mkt cap, 14-Jun-2018
Corvus Pharmaceuticals Net income (Q1, 2018)-14.3 M
Corvus Pharmaceuticals EBIT (Q1, 2018)-14.6 M
Corvus Pharmaceuticals Cash, 31-Mar-2018102.6 M

Corvus Pharmaceuticals Financials

Corvus Pharmaceuticals Income Statement

Annual

USDFY, 2016

R&D expense

38 k

General and administrative expense

123 k

Operating expense total

161 k

EBIT

(161 k)

Net Income

(161 k)

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

R&D expense

7.7 m13.5 m12.4 m12.1 m

General and administrative expense

2.8 m2.7 m2.8 m2.5 m

Operating expense total

10.5 m16.2 m15.2 m14.6 m

EBIT

(10.5 m)(16.2 m)(15.2 m)(14.6 m)

Interest income

181 k193 k343 k

Net Income

(6.3 m)(15 m)(10.3 m)(16 m)(15 m)(14.3 m)

Corvus Pharmaceuticals Balance Sheet

Quarterly

USDQ1, 2016Q2, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

4.1 m4.3 m10.5 m34.1 m102.6 m

Current Assets

154.1 m153.5 m123.1 m111.6 m145.2 m

PP&E

2.6 m2.8 m3.1 m3 m2.5 m

Total Assets

157.2 m156.9 m127.1 m115.5 m148.7 m

Accounts Payable

1.6 m1.3 m2.4 m4.1 m3.5 m

Current Liabilities

3.4 m3.6 m7.6 m9.5 m10.6 m

Total Liabilities

4.7 m5 m8.9 m10.7 m11.5 m

Additional Paid-in Capital

190.4 m198.4 m202.2 m203.7 m275.1 m

Retained Earnings

(37.8 m)(46.5 m)(83.9 m)(98.9 m)(137.8 m)

Total Equity

152.6 m152 m118.2 m104.8 m137.2 m

Financial Leverage

1 x1 x1.1 x1.1 x1.1 x

Corvus Pharmaceuticals Cash Flow

Annual

USDFY, 2016

Net Income

(161 k)

Accounts Payable

1.9 m

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(6.3 m)(15 m)(10.3 m)(16 m)(14.3 m)

Depreciation and Amortization

106 k250 k219 k

Accounts Payable

(193 k)129 k2.4 m2.4 m45 k

Cash From Operating Activities

(5.6 m)(11.8 m)(11 m)

Purchases of PP&E

(614 k)(1.5 m)(6 k)

Cash From Investing Activities

(58.7 m)(59.4 m)3.6 m

Cash From Financing Activities

64.3 m71.4 m64.9 m

Corvus Pharmaceuticals Ratios

USDY, 2018

Financial Leverage

1.1 x
Report incorrect company information

Corvus Pharmaceuticals Operating Metrics

Corvus Pharmaceuticals's Patent Applications was reported to be 11 in FY, 2016.
FY, 2016

Patent Applications

11

Patents Licensed

18
Report incorrect company information